Robotic Exoskeleton Gait Training During Acute Stroke Rehabilitation

NCT04775693 | Unknown FDA Device

• 1 other identifier: R-911-16
• Study Type: interventional
• Target: 96
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this RCT is to explore the clinical, functional and neurophysiological effectiveness of RE-assisted (Robotic Exoskeleton) early intervention gait therapy in stroke patients during inpatient and outpatient stroke rehabilitation as compared to traditional gait training in three groups: 1) RE; 2) RE-Standard of Care (SOC) and 3) SOC. We will evaluate the short and long-term effects on functional mobility, clinical, neurophysiological, community participation and quality of life.

Conditions

Stroke, Acute

Keywords

hemiplegia; robotic; exoskeleton; gait

Outcome Measures

Primary Outcomes (11)

• Functional Independence Measure (FIM)

  a conventional assessment measure of motor function

  6 months

• TUG

  time up and go (TUG) test

  6 months

• BBA

  Berg Balance Assessment (BBA)

  6 months

• ROM

  range of motion (ROM)- conventional assessment performed by a physical therapist

  6 months

• strength

  conventional assessment performed by a physical therapist

  6 months

• temporal spatial parameters

  collected though motion capture camera system

  6 months

• plantar loading

  use of shoe insoles to gather information about foot pressure

  6 months

• electromyography (EMG)

  a measure of muscle activation (EMG signal) at different phases of gait cycle (swing versus double support).

  6 months

• SIS

  stroke impact scale (SIS). questionnaire about quality of life post-stroke

  6 months

• LIFE-H

  assessment of life habits (LIFE-H). questionnaire about quality of life post-stroke

  6 months

• SSQoL

  stroke specific quality of life scale (SSQoL). questionnaire about quality of life post-stroke

  6 months

Study Arms (3)

RE

EXPERIMENTAL

Participants use the robotic exoskeleton (RE) in addition to their standard of care gait training as both an inpatient (2 days a week RE) and an outpatient (3 days a week RE).

Device: RE (Robotic Exoskeleton)

SOC

ACTIVE COMPARATOR

Participants receive standard of care gait training only as both an inpatient (at least 2 days a week) and an outpatient (at least 3 days a week).

Other: SOC (standard of care)

RE/SOC

EXPERIMENTAL

Participants use the robotic exoskeleton (RE) in addition to their standard of care gait training as an inpatient (2 days a week RE) and standard of care only as an outpatient (at least 3 days a week).

Device: RE (Robotic Exoskeleton)

Interventions

RE (Robotic Exoskeleton) DEVICE

Participants will continue to receive their prescribed standard of care physical therapy/gait training. They will also utilize the robotic exoskeleton twice a week during their inpatient stay and 3 times a week for 5 weeks as an outpatient (for outpatient, only if in the RE group). The Robotic Exoskeleton is a device that will be strapped to the chest and legs and worn over the shoulders like a backpack that will assist in walking. It uses sensors and participant motion to move. A licensed physical therapist will be assisting participants as they use the device.

RE; RE/SOC

SOC (standard of care) OTHER

Traditional physical therapist driven gait training.

SOC

Eligibility Criteria

• Age: 21 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Stroke survivors \< 4 weeks from most recent stroke.
• Age: 21- 80 years
• Unilateral hemiparesis
• Medical clearance by a Kessler Institute for Rehabilitation physician.
• Be able to physically fit into the exoskeleton device.
• Be able to tolerate upright standing for 30 minutes.
• Have joint range of motion within normal functional limits for ambulation.
• Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE.
• Have stable blood pressure; no diagnosis of persistent orthostatic hypotension (blood pressure drop of more than 30 millimeters of Mercury in body weight support system).
• Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation, e.g. can follow directions as determined by a Kessler Institute for Rehabilitation physician or physical therapist.
• No history of injury or pathology to the unaffected limb.

You may not qualify if:

• Unable to physically fit within the RE: Height below 60" or above 76" and weight above 220 lbs.
• Joint contracture or spasticity of any limb that limits normal ROM during ambulation with assistive devices.
• Any medical issue that precludes full weight bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity).
• Skin issues that would prevent wearing the device.
• Pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance.
• Pre-existing condition that caused exercise intolerance.(Documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure)
• Hospitalization for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.
• Severe cognitive or psychiatric problems as well as incontinence might be contraindications to start training with a RE.
• History of severe cardiac disease such as myocardial infarction, congestive heart failure.
• Uncontrolled seizure disorder.
• Uncontrolled spasticity that would interfere with walking in the RENeuromuscular or neurological pathologies (e.g., Parkinson's disease, spinal cord injury, or traumatic brain injury with evidence of motor weakness and multiple sclerosis) that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs
• Orthopedic pathologies or history that will interfere with ambulation or limit the range of motion of the lower limbs (e.g., knee replacement, fixed contractures, inflammation)
• Pregnant as confirmed by pregnancy test.

Sponsors & Collaborators

• Kessler Foundation: lead

Study Sites (1)

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location

MeSH Terms

Conditions

Stroke; Hemiplegia

Interventions

Exoskeleton Device; Standard of Care

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Paralysis; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Equipment and Supplies; Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Study Officials

• Karen J Nolan, PhD

  Kessler Foundation

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 3, 2021
• First Posted: March 1, 2021
• Study Start: May 12, 2017
• Primary Completion: December 1, 2021
• Study Completion: December 1, 2022
• Last Updated: March 1, 2021

Record last verified: 2021-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)